Add Papers Marked0
Paper checked off!

Marked works

Viewed0

Viewed works

Shopping Cart0
Paper added to shopping cart!

Shopping Cart

Register Now

eKönyvtár library
FAQ
Special offers 2 Open

Great deal: today with a discount!

Regular price:
1 354 Ft
You save:
256 Ft
Discounted price*:
1 098 Ft
Purchase
Add to Wish List
ID number:845463
Evaluation:
Published: 22.07.2006.
Language: English
Level: Secondary school
Literature: n/a
References: Not used
Extract

After 4 years hard working, 30 million dollars in acquiring Angiomax, further R&D, and initiate marketing test, in order to successfully market the first flagship drug Angiomax, the Medicines Company now have a couple of decisions to make in terms of initial pricing, segmentation, marketing strategies, etc (see exhibit 1).
Decision I: At what initial price should Angiomax be offered to the market? Which segments should be targeted first? Why?

Load more similar papers

Send to email

Your name:

Enter an email address where the link will be sent:

Hi!
{Your name} suggests you to check out this eKönyvtár paper on „Angiomax”.

Link to paper:
https://eng.ekonyvtar.eu/w/845463

Send

Email has been sent

Choose Authorization Method

Email & Password

Email & Password

Wrong e-mail adress or password!
Log In

Forgot your password?

Facebook

Not registered yet?

Register and redeem free papers!

To receive free papers from eKönyvtár.com it is necessary to register. It's quick and will only take a few seconds.

If you have already registered, simply to access the free content.

Cancel Register